Editing Patient Pathways: Colon Cancer (section)

== 2. Treatment ==

'''Multidisciplinary Team (MDT) meeting'''

'''MDT discussion:''' Review of diagnostic findings with specialists including endocrinologists, surgeons, oncologists, radiologists and pathologists. Development of a treatment plan: Based on the stage of colon cancer and the patient’s overall health.

'''Treatment options'''

'''Surgery'''

Surgery is the primary treatment for localized colon cancer. For stage III, adjuvant chemotherapy with fluoropyrimidine and oxaliplatin (FOLFOX or CAPOX) is the standard of care.

'''Chemotherapy'''

Adjuvant chemotherapy is recommended for patients with stage III and high-risk stage II. Treatment is usually given for 3 to 6 months, depending on the specific regimen and risk of recurrence.

'''Targeted Therapy'''

Patients with metastatic colorectal cancer may receive EGFR-directed therapies (if they do not have KRAS/NRAS mutations) or VEGF, as well as BRAF inhibitors for patients with the BRAF V600E mutation.

<span id="after-treatment-follow-up-rehabilitation-and-survival"></span>